HIV-1 Proviral DNA Excision Using an Evolved Recombinase

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Science

• Publication date

  2007-06-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/science.1141453PMID 17600219
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Site-specific recombination of asymmetric lox sites mediated by a heterotetrameric Cre recombinase complex.

  2006cited by this paper
• Current issues in mouse genome engineering

  2005cited by this paper
• Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy.

  2005cited by this paper
• Site-specific DNA recombinases as instruments for genomic surgery.

  2005cited by this paper
• Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells

  2005cited by this paper
• Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins.

  2005cited by this paper
• Evolving strategies for enzyme engineering.

  2005cited by this paper
• Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus Macaques

  2004cited by this paper
• Mechanisms of site-specific recombination.

  2003cited by this paper
• Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.

  2003cited by this paper
• Directed evolution of the site specificity of Cre recombinase

  2002cited by this paper
• Non-contact positions impose site selectivity on Cre recombinase

  2002cited by this paper
• Antiretroviral-drug resistance among patients recently infected with HIV.

  2002cited by this paper
• A structural view of cre-loxp site-specific recombination.

  2001cited by this paper
• A structural view of cre-loxp site-specific recombination.

  2001cited by this paper
• In vitro evolution of beta-glucuronidase into a beta-galactosidase proceeds through non-specific intermediates.

  2001cited by this paper
• Alteration of Cre recombinase site specificity by substrate-linked protein evolution

  2001cited by this paper
• Conditional control of gene expression in the mouse

  2001cited by this paper
• Transmission of human immunodeficiency type 1 viruses with intersubtype recombinant long terminal repeat sequences.

  1999cited by this paper
• A novel mutant loxP containing part of long terminal repeat of HIV-1 in spacer region: presentation of possible target site for antiviral strategy using site-specific recombinase.

  1998cited by this paper
• AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor

  1998cited by this paper
• HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology.

  1998cited by this paper
• Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.

  1997cited by this paper
• Inhibition of recombinant human immunodeficiency virus type 1 replication by a site-specific recombinase

  1997cited by this paper

• S-SELeCT: A Human-Evolved Serine Integrase System for Efficient Large-Cargo Genome Integration

  2026cites this paper
• Recent advances in therapeutic gene editing technologies.

  2025cites this paper
• Development of Donor DNA Construct for RNA-Guided Recombinase (RGR) Genome Editing Platform-mediated Knockout of Myostatin b (mstnb) Gene in Zebrafish

  2025cites this paper
• Development of 2LTRZFP-expressing induced pluripotent stem cells as a potential anti-HIV-1 gene therapy against viral integration.

  2025cites this paper
• Enhancing Specificity, Precision, Accessibility, Flexibility, and Safety to Overcome Traditional CRISPR/Cas Editing Challenges and Shape Future Innovations

  2025cites this paper
• Activation of recombinases at specific DNA loci by zinc-finger domain insertions

  2024cites this paper
• Preclinical toxicity analyses of lentiviral vectors expressing the HIV-1 LTR-specific designer-recombinase Brec1

  2024cites this paper
• Regulation of expression of unintegrated and integrated HIV-1 DNA: keeping the wolves at bay

  2024cites this paper
• Engineering spacer specificity of the Cre/loxP system

  2024cites this paper
• Dynamics in Cre-loxP site-specific recombination.

  2024cites this paper
• Engineering structural variants to interrogate genome function

  2024cites this paper
• HIV Persistence, Latency, and Cure Approaches: Where Are We Now?

  2024cites this paper
• Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells

  2024cites this paper
• Genome editing and its role in vaccine, diagnosis, and therapeutic advancement.

  2024cites this paper
• Quantification of evolved DNA-editing enzymes at scale with DEQSeq

  2023cites this paper
• Discovery and characterization of novel Cre-type tyrosine site-specific recombinases for advanced genome engineering

  2023cites this paper
• HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing

  2023cites this paper
• Precise excision of HTLV-1 provirus with a designer-recombinase

  2023cites this paper
• Milk Transmission of HTLV-1 and the Need for Innovative Prevention Strategies

  2022influential citation
• Recent Advances in Double-Strand Break-Free Kilobase-Scale Genome Editing Technologies.

  2022cites this paper
• Conformational dynamics promotes disordered regions from function-dispensable to essential in evolved site-specific DNA recombinases

  2022cites this paper
• Nearest-Neighbor Effects Modulate loxP Spacer DNA Chemical Shifts and Guide Oligonucleotide Design for Nuclear Magnetic Resonance Studies.

  2022cites this paper
• CRISPR/Cas9: a tool to eradicate HIV-1

  2022cites this paper
• Prediction of designer-recombinases for DNA editing with generative deep learning

  2022influential citation
• Mechanisms of Cre recombinase synaptic complex assembly and activation illuminated by Cryo-EM

  2022cites this paper
• Functional cure of a chronic virus infection by shifting the virus - host equilibrium state

  2022cites this paper
• HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies

  2022cites this paper
• Nearest-neighbor effects modulate loxP spacer DNA chemical shifts and guide oligonucleotide design for NMR studies

  2021cites this paper
• Multiplexed Simian Immunodeficiency Virus-Specific Paired RNA-Guided Cas9 Nickases Inactivate Proviral DNA

  2021cites this paper
• DNA methylation occurring in Cre-expressing cells inhibits loxP recombination and silences loxP-sandwiched genes.

  2021cites this paper
• HIV-1 and human genetic variation

  2021cites this paper
• Pairing of single mutations yields obligate Cre-type site-specific recombinases

  2021cites this paper
• Editing out HIV: application of gene editing technology to achieve functional cure

  2021cites this paper
• Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors

  2020cites this paper
• Genome targeting by hybrid Flp-TAL recombinases

  2020cites this paper
• Development of an algorithm to deplete pseudo-ITR structures from AAV transgenes Study Project Exposé

  2020cites this paper
• Correction of a Factor VIII genomic inversion with designer-recombinases

  2020cites this paper
• Protein Delivery of Cell-Penetrating Zinc-Finger Activators Stimulates Latent HIV-1-Infected Cells

  2020cites this paper
• Non-viral strategies for delivering genome editing enzymes.

  2020cites this paper
• Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1+ and TIGIT+ CD4 T Cells

  2019cites this paper
• The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape

  2019cites this paper
• Nanotechnology approaches to eradicating HIV reservoirs

  2019cites this paper
• Elimination of infectious HIV DNA by CRISPR–Cas9

  2019cites this paper
• Preparing biomedical students for the unknown

  2019cites this paper
• Exploration of RNA-Guided Recombinase Target Sites for Hyperactivated Recombinase Beta in Bovine Genome

  2019cites this paper
• Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy

  2019cites this paper
• A heterodimer of evolved designer-recombinases precisely excises a human genomic DNA locus

  2019cites this paper
• High-resolution specificity profiling and off-target prediction for site-specific DNA recombinases

  2019cites this paper
• The latest evidence for possible HIV-1 curative strategies

  2018cites this paper
• Noncoding RNAs in Retrovirus Replication

  2018cites this paper
• CRISPR/Cas9 and Genome Editing for Viral Disease-Is Resistance Futile?

  2018cites this paper
• Viral diversity is an obligate consideration in CRISPR/Cas9 designs for HIV cure

  2018cites this paper
• Engineering altered protein–DNA recognition specificity

  2018cites this paper
• Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting the HIV reservoir

  2018cites this paper
• Interaction between the cellular E3 ubiquitin ligase SIAH-1 and the viral immediate-early protein ICP0 enables efficient replication of Herpes Simplex Virus type 2 in vivo

  2018cites this paper
• Dual Recombinase-Mediated Cassette Exchange by Tyrosine Site-Specific Recombinases.

  2017cites this paper
• Crystal structure of an engineered, HIV-specific recombinase for removal of integrated proviral DNA

  2017influential citation
• CRISPR-Cas based antiviral strategies against HIV-1.

  2017cites this paper
• Strategien zur Inhibierung der HIV-Reaktiverung in latent infizierten Astrozyten

  2017cites this paper
• Gene Therapy Approaches to Human Immunodeficiency Virus and Other Infectious Diseases.

  2017cites this paper
• Live cell imaging of single genomic loci with quantum dot-labeled TALEs

  2017cites this paper
• Designer-Rekombinasen für präzises Genome Editing

  2017cites this paper
• Gene-targeted strategies to eliminate HIV latent cells through synthetic activators and suicide lentivectors

  2017cites this paper
• Novel AIDS therapies based on gene editing

  2017cites this paper
• Gene Therapy Blueprints for NeuroAIDS

  2017cites this paper
• Fight fire with fire: Gene therapy strategies to cure HIV

  2017cites this paper
• Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape

  2016cites this paper
• Using Engineered Nucleases to Create HIV-Resistant Cells

  2016cites this paper
• Detection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy.

  2016cites this paper
• Engineering Cre Recombinase for Genome Engineering

  2016cites this paper
• [Application progress of CRISPR/Cas9 genome editing technology in the treatment of HIV-1 infection].

  2016cites this paper
• Discovery of Nigri/nox and Panto/pox site-specific recombinase systems facilitates advanced genome engineering

  2016cites this paper
• Site-specific recombinases: molecular machines for the Genetic Revolution.

  2016cites this paper
• HIV: Treatment and Comorbidity

  2016cites this paper
• Genome engineering: Drosophila melanogaster and beyond

  2016cites this paper
• Attacking HIV-1 RNA versus DNA by sequence-specific approaches: RNAi versus CRISPR-Cas.

  2016cites this paper
• Clinical Applications of Genome Editing to HIV Cure

  2016cites this paper
• Lessons From HIV-1 Gene Therapy in Humanized Mice: Is Targeting Viral Entry the Road to Success?

  2016cites this paper
• Nuclear landscape of HIV-1 infection and integration

  2016cites this paper
• Stem cell-based therapies for HIV/AIDS.

  2016cites this paper
• Antiviral therapy of persistent viral infection using genome editing.

  2016cites this paper
• Cre Recombinase and Other Tyrosine Recombinases.

  2016cites this paper
• Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity

  2016cites this paper
• Genome engineering in mammalian cells by Flp and Cre DNA recombinase variants

  2016cites this paper
• Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems

  2016cites this paper
• Genome editing for clinical HIV isolates

  2016cites this paper
• The clinical applications of genome editing in HIV.

  2016influential citation
• Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors

  2016cites this paper
• Second European Round Table on the Future Management of HIV

  2015cites this paper
• Target‐specific variants of Flp recombinase mediate genome engineering reactions in mammalian cells

  2015cites this paper
• Divergent evolution of a bifunctional de novo protein

  2015cites this paper
• CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape

  2015cites this paper
• Recent advances in developing molecular tools for targeted genome engineering of mammalian cells

  2015cites this paper
• Prospects for using self-assembled nucleic acid structures

  2015cites this paper
• Engineering T Cells to Functionally Cure HIV-1 Infection.

  2015cites this paper
• An Overview of Tyrosine Site-specific Recombination: From an Flp Perspective

  2015cites this paper
• Redesign of the monomer–monomer interface of Cre recombinase yields an obligate heterotetrameric complex

  2015cites this paper
• Potential mechanisms for cell-based gene therapy to treat HIV/AIDS

  2015cites this paper
• Damaging the Integrated HIV Proviral DNA with TALENs

  2015cites this paper
• Inhibition of HIV-1 Viral Infection by an Engineered CRISPR Csy4 RNA Endoribonuclease

  2015influential citation